These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37850364)

  • 1. Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold.
    Romagnoli R; De Ventura T; Manfredini S; Baldini E; Supuran CT; Nocentini A; Brancale A; Bortolozzi R; Manfreda L; Viola G
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2270180. PubMed ID: 37850364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro and in-silico investigations of SLC-0111 hydrazinyl analogs as human carbonic anhydrase I, II, IX, and XII inhibitors.
    Sharma V; Vats L; Giovannuzzi S; Mohan B; Supuran CT; Sharma PK
    Arch Pharm (Weinheim); 2024 Aug; 357(8):e2400157. PubMed ID: 38713910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors.
    El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Alanazi MM; El-Gendy MA; Ahmed HEA; Supuran CT
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):733-743. PubMed ID: 32189526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action.
    Havránková E; Csöllei J; Vullo D; Garaj V; Pazdera P; Supuran CT
    Bioorg Chem; 2018 Apr; 77():25-37. PubMed ID: 29324250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors.
    Buza A; Türkeş C; Arslan M; Demir Y; Dincer B; Nixha AR; Beydemir Ş
    Int J Biol Macromol; 2023 Jun; 239():124232. PubMed ID: 37001773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors.
    Kumar A; Siwach K; Rom T; Kumar R; Angeli A; Kumar Paul A; Supuran CT; Sharma PK
    Bioorg Chem; 2022 Jun; 123():105764. PubMed ID: 35366582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide based thiosemicarbazides as potent and selective inhibitors of tumor-associated human carbonic anhydrase IX and XII: Synthesis, cytotoxicity, and molecular modelling studies.
    Demir-Yazıcı K; Trawally M; Bua S; Öztürk-Civelek D; Akdemir A; Supuran CT; Güzel-Akdemir Ö
    Bioorg Chem; 2024 Mar; 144():107096. PubMed ID: 38290186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Pyridinium Salt Derivatives of 2-(Hydrazinocarbonyl)-3-phenyl-1H-indole-5- sulfonamide as Selective Inhibitors of Tumour-Related Human Carbonic Anhydrase Isoforms IX and XII.
    Güzel-Akdemir Ö; Demir-Yazıcı K; Vullo D; Supuran CT; Akdemir A
    Anticancer Agents Med Chem; 2022; 22(14):2637-2646. PubMed ID: 35135455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
    Sarikaya B; Ceruso M; Carta F; Supuran CT
    Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors.
    Moi D; Vittorio S; Angeli A; Balboni G; Supuran CT; Onnis V
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfocoumarin-, Coumarin-, 4-Sulfamoylphenyl-Bearing Indazole-3-carboxamide Hybrids: Synthesis and Selective Inhibition of Tumor-Associated Carbonic Anhydrase Isozymes IX and XII.
    Angapelly S; Sri Ramya PV; Angeli A; Supuran CT; Arifuddin M
    ChemMedChem; 2017 Oct; 12(19):1578-1584. PubMed ID: 28940980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organoruthenium(II) complexes of acetazolamide potently inhibit human carbonic anhydrase isoforms I, II, IX and XII.
    Seršen S; Traven K; Kljun J; Turel I; Supuran CT
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):388-393. PubMed ID: 30734595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 6-tetrazolyl-substituted sulfocoumarins acting as highly potent and selective inhibitors of the tumor-associated carbonic anhydrase isoforms IX and XII.
    Grandane A; Tanc M; Zalubovskis R; Supuran CT
    Bioorg Med Chem; 2014 Mar; 22(5):1522-8. PubMed ID: 24513186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3
    Pustenko A; Balašova A; Nocentini A; Supuran CT; Žalubovskis R
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):216-224. PubMed ID: 36377338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
    Ibrahim DA; Lasheen DS; Zaky MY; Ibrahim AW; Vullo D; Ceruso M; Supuran CT; Abou El Ella DA
    Bioorg Med Chem; 2015 Aug; 23(15):4989-4999. PubMed ID: 26048024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of carbonic anhydrase IX by sulphonylated 1,2,3-triazole incorporated benzenesulphonamides capable of inducing apoptosis.
    Siwach K; Kumar A; Panchal H; Kumar R; Bhardwaj JK; Angeli A; Supuran CT; Sharma PK
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1454-1463. PubMed ID: 35616287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
    Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
    Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII.
    Grandane A; Tanc M; Zalubovskis R; Supuran CT
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1256-60. PubMed ID: 24518190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.